Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 11, 2022 08:00 ET
|
Absci Corp
VANCOUVER, Wash., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci Announces Research Collaboration with Merck
January 07, 2022 05:00 ET
|
Absci Corp
VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
December 30, 2021 08:05 ET
|
Absci Corp
VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci Reports Third Quarter 2021 Financial and Operating Results
November 09, 2021 07:00 ET
|
Absci Corp
VANCOUVER, Wash., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci to Participate in Upcoming November 2021 Investor Conferences
October 28, 2021 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci Opens Door to New Biotechnology Campus
October 20, 2021 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
Absci to Report Third Quarter Financial Results on November 9, 2021
October 14, 2021 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
October 06, 2021 06:00 ET
|
Absci Corp
CAMBRIDGE, Mass. and VANCOUVER, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at...